124 related articles for article (PubMed ID: 31009117)
1. Erythrocytes restrict microvesicle-induced production of reactive oxygen species by polymorphonuclear leukocytes.
Winberg LK; Rasmussen NS; Nielsen CH; Jacobsen S
APMIS; 2019 Jul; 127(7):538-542. PubMed ID: 31009117
[TBL] [Abstract][Full Text] [Related]
2. Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.
Karasu E; Demmelmaier J; Kellermann S; Holzmann K; Köhl J; Schmidt CQ; Kalbitz M; Gebhard F; Huber-Lang MS; Halbgebauer R
Front Immunol; 2020; 11():1789. PubMed ID: 32983087
[TBL] [Abstract][Full Text] [Related]
3. Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes.
Winberg LK; Jacobsen S; Nielsen CH
Arthritis Res Ther; 2017 Oct; 19(1):230. PubMed ID: 29041967
[TBL] [Abstract][Full Text] [Related]
4. The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway.
Wu K; Yang Y; Zhong Y; Ammar HM; Zhang P; Guo R; Liu H; Cheng C; Koroscil TM; Chen Y; Liu S; Bihl JC
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E828-37. PubMed ID: 26956185
[TBL] [Abstract][Full Text] [Related]
5. Microparticle formation after co-culture of human whole blood and umbilical artery in a novel in vitro model of flow.
Holtom E; Usherwood JR; Macey MG; Lawson C
Cytometry A; 2012 May; 81(5):390-9. PubMed ID: 22213485
[TBL] [Abstract][Full Text] [Related]
6. Intra-alveolar neutrophil-derived microvesicles are associated with disease severity in COPD.
Soni S; Garner JL; O'Dea KP; Koh M; Finney L; Tirlapur N; Srikanthan K; Tenda ED; Aboelhassan AM; Singh S; Wilson MR; Wedzicha JA; Kemp SV; Usmani OS; Shah PL; Takata M
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L73-L83. PubMed ID: 33146567
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement.
Zecher D; Cumpelik A; Schifferli JA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):313-20. PubMed ID: 24311376
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-Derived Procoagulant Microvesicles Induced by High Glucose Can Be Attenuated by the Antioxidant N-Acetyl-L-Cysteine, Partly Through the P38/MAPK Pathway.
Li M; Zhang X; Yu J; Wu X; Sun L
Metab Syndr Relat Disord; 2017 Dec; 15(10):521-526. PubMed ID: 29125808
[TBL] [Abstract][Full Text] [Related]
9. Enumeration and phenotyping of circulating microvesicles by flow cytometry and nanoparticle tracking analysis: Plasma versus serum.
Siwaponanan P; Keawvichit R; Lekmanee K; Chomanee N; Pattanapanyasat K
Int J Lab Hematol; 2021 Jun; 43(3):506-514. PubMed ID: 33244869
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylserine expressing microvesicles in relation to microvascular complications in type 1 diabetes.
Bergen K; Mobarrez F; Jörneskog G; Wallén H; Tehrani S
Thromb Res; 2018 Dec; 172():158-164. PubMed ID: 30447538
[TBL] [Abstract][Full Text] [Related]
11. [The influence of erythrocyte-derived microvesicles on aggregation of platelets in burn injury].
Levin GY; Sukhareva EG
Patol Fiziol Eksp Ter; 2015; (3):62-8. PubMed ID: 26852598
[TBL] [Abstract][Full Text] [Related]
12. The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment.
Mobarrez F; Abraham-Nordling M; Aguilera-Gatica K; Friberg I; Antovic A; Pisetsky DS; Jörneskog G; Wallen H
Clin Endocrinol (Oxf); 2016 May; 84(5):729-35. PubMed ID: 26252432
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between complement activation and reactive oxygen species generation in inflammatory response].
Fan X; Ling Y; Wu Y; Hou J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):170-4. PubMed ID: 12569648
[TBL] [Abstract][Full Text] [Related]
14. In vitro Incubation of Platelets with oxLDL Does Not Induce Microvesicle Release When Measured by Sensitive Flow Cytometry.
Nielsen TB; Nielsen MH; Handberg A
Front Cardiovasc Med; 2015; 2():37. PubMed ID: 26664908
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Microvesicles Released from Human Red Blood Cells.
Nguyen DB; Ly TB; Wesseling MC; Hittinger M; Torge A; Devitt A; Perrie Y; Bernhardt I
Cell Physiol Biochem; 2016; 38(3):1085-99. PubMed ID: 26938586
[TBL] [Abstract][Full Text] [Related]
16. Circulating Microvesicles Are Elevated Acutely following Major Burns Injury and Associated with Clinical Severity.
O'Dea KP; Porter JR; Tirlapur N; Katbeh U; Singh S; Handy JM; Takata M
PLoS One; 2016; 11(12):e0167801. PubMed ID: 27936199
[TBL] [Abstract][Full Text] [Related]
17. Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in vitro.
Guo HM; Sun L; Yang L; Liu XJ; Nie ZY; Luo JM
Oncol Rep; 2018 Jun; 39(6):2873-2880. PubMed ID: 29693175
[TBL] [Abstract][Full Text] [Related]
18. Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha.
Nguyen HX; O'Barr TJ; Anderson AJ
J Neurochem; 2007 Aug; 102(3):900-12. PubMed ID: 17561941
[TBL] [Abstract][Full Text] [Related]
19. Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases.
Chen Y; Li G; Liu ML
Genomics Proteomics Bioinformatics; 2018 Feb; 16(1):50-62. PubMed ID: 29462670
[TBL] [Abstract][Full Text] [Related]
20. Circulating membrane-derived microvesicles in redox biology.
Larson MC; Hillery CA; Hogg N
Free Radic Biol Med; 2014 Aug; 73():214-28. PubMed ID: 24751526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
